Ambev SA (NASDAQ:ABEV) has received a consensus rating of “Buy” from the seven brokerages that are presently covering the stock, American Banking News reports. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. On Friday shares of Ambev S.A. (NYSE:ABEV) closed at $6.36. Company’s EPS growth for next 5 years is recorded as 7.09%.
On February 17, Aoxing Pharmaceutical Company, Inc. (NYSEMKT:AXN) announced its financial and operational results for the quarter ended December 31, 2014. Revenues in the second quarter increased 85% year over year to $6.4 million while cost of sales decreased 20% year over year to $1.6 million. Gross profit for the second quarter was $4.8 million, representing a 75% gross margin, and an increase of 233% as compared to the same quarter last year. Aoxing Pharmaceutical Company, Inc. (NYSEMKT:AXN) in last trading activity increased 65.25% to close at $1.95. Company weekly performance is 282.35% while its quarterly performance stands at 875.00%. Aoxing Pharmaceutical Company, Inc. (NYSEMKT:AXN) is 56.00% away from its 52 week high.
On February 12, Century Aluminum Company (NASDAQ:CENX) announced that Rick Dillon, Century’s Executive Vice President and Chief Financial Officer, will take a temporary medical leave of absence. Mr. Dillon is expected to return by the end of the first quarter. In the interim, Mr. Dillon’s duties and responsibilities will be assumed by Michael Bless, Century’s President and Chief Executive Officer. On last trading day Century Aluminum Co. (NASDAQ:CENX) remains unchanged to close at $22.16. Its volatility for the week is 3.32% while volatility for the month is 4.74%. CENX’s sales growth for past 5 years was -5.90% and its EPS growth for past 5 years was 53.20%. Century Aluminum Co. (NASDAQ:CENX) monthly performance is -6.06%.
Solitario Exploration & Royalty Corp. (NYSEMKT:XPL) has 3.80% insider ownership while its institutional ownership stands at 18.30%. In last trading activity company’s stock closed at $0.84.
On Feb 19, Build-A-Bear Workshop Inc. (NYSE:BBW) reported results for the fourth quarter and fiscal year ended January 3, 2015. Consolidated net retail sales were $130.0 million, compared to $106.3 million in the fiscal 2013 fourth quarter (13 weeks ended December 28, 2013). On last trading day Build-A-Bear Workshop Inc. (NYSE:BBW) moved down -5.33% to close at $19.37. Its volatility for the week is 8.28% while volatility for the month is 5.43%. BBW’s sales growth for past 5 years was -4.10% and its EPS growth for past 5 years was -20.50%. Build-A-Bear Workshop Inc. (NYSE:BBW) monthly performance is -7.19%.